12.25GBp+2.04%Mkt Cap: 29.50M GBpP/E: —Last update: 2026-05-13
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)76.67
PEG—
P/B7.67
P/S3.02
EV/EBITDA-13.77
EV/Revenue4.92
EPS (TTM)-0.01
EPS (Forward)0.00
Cash Flow & Leverage
FCF Yield-4.98%
FCF Margin-15.34%
Operating CF-3.18M GBp
CapEx (TTM)346.00K GBp
Net Debt/EBITDA0.81
Net Debt-2.76M GBp
Technical
SMA 509.010 (+36.0%)
SMA 2007.020 (+74.5%)
Beta0.12
S&P 52W Chg24.23%
Avg Vol (30d)546.00K
Avg Vol (10d)1.29M
Technical Indicators
RSI (14)72.9
MACD1.0910
MACD Signal0.8497
MACD Hist.+0.2413
BB Upper13.43 GBp
BB Middle10.32 GBp
BB Lower7.220 GBp
BB Width60.12%
ATR (14)1.090 GBp
Vol Ratio (20d)0.24x
52W Range
5.10091% of range13.00
52W High13.00 GBp
52W Low5.100 GBp
Profitability
Gross Margin44.32%
EBITDA Margin-35.73%
Profit Margin-40.51%
Oper. Margin-53.88%
ROE-64.43%
ROA-36.67%
Revenue Growth36.90%
Earnings Growth—
Balance Sheet
Debt/Equity0.19
Current Ratio1.91
Quick Ratio1.73
Book Value/Sh0.0150 GBp
Cash/Share0.0090 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.251.08M
Float167.62M
Insiders31.05%
Institutions31.77%
Analyst Consensus
Rating—
Target (Mean)19.00 GBp
Target Range19.00 GBp – 19.00 GBp
# Analysts1
Company
Market Cap29.50M GBp
Enterprise Value47.08M GBp
Revenue (TTM)9.57M GBp
Gross Profit3.74M GBp
Net Income (TTM)-3.42M GBp
Revenue/Share0.0250 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees129
Last Price12.25 GBp
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—